Gene · 7994
Papers1,720
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,720
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New insights into fibrotic signaling in renal cell carcinoma. | Front Cell Dev Biol | 2023 | 36910160 | PubTator, text mining | PubMed |
| Atypical histone targets of PHD fingers. | J Biol Chem | 2023 | 36907441 | PubTator, text mining | PubMed |
| The Role of Histone Modification in DNA Replication-Coupled Nucleosome Assembly and Cancer. | Int J Mol Sci | 2023 | 36902370 | PubTator, text mining | PubMed |
| Circular RNA Expression Signatures Provide Promising Diagnostic and Therapeutic Biomarkers for Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2023 | 36900344 | PubTator, text mining | PubMed |
| Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cells. | Cancer Cell | 2023 | 36898380 | PubTator, text mining | PubMed |
| Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity. | Nat Cancer | 2023 | 36894639 | PubTator, text mining | PubMed |
| A case of KAT6A syndrome with a newly discovered mutation in the KAT6A gene, mainly manifested as bone marrow failure syndrome. | Hematology | 2023 | 36880793 | PubTator, text mining | PubMed |
| Histone malonylation is regulated by SIRT5 and KAT2A. | iScience | 2023 | 36879797 | PubTator, text mining | PubMed |
| Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. | Signal Transduct Target Ther | 2023 | 36864020 | PubTator, text mining | PubMed |
| Regulatory de novo mutations underlying intellectual disability. | Life Sci Alliance | 2023 | 36854624 | PubTator, text mining | PubMed |
| Mutational Damages in Malignant Lung Tumors. | Asian Pac J Cancer Prev | 2023 | 36853323 | PubTator, text mining | PubMed |
| Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing. | Blood Adv | 2023 | 36848637 | PubTator, text mining | PubMed |
| Tumor Androgen Receptor Protein Level Is Positively Associated with a Better Overall Survival in Melanoma Patients. | Genes (Basel) | 2023 | 36833272 | PubTator, text mining | PubMed |
| The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies. | Cancers (Basel) | 2023 | 36831561 | PubTator, text mining | PubMed |
| Congenital Microcephaly: A Debate on Diagnostic Challenges and Etiological Paradigm of the Shift from Isolated/Non-Syndromic to Syndromic Microcephaly. | Cells | 2023 | 36831309 | PubTator, text mining | PubMed |
| The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context. | Cells | 2023 | 36831308 | PubTator, text mining | PubMed |
| Case Report: Disease progression of renal cell carcinoma containing a novel putative pathogenic KAT6A::NRG1 fusion on Ipilimumab- Nivolumab immunotherapy. A case study and review of the literature. | Front Oncol | 2023 | 36816927 | PubTator, text mining | PubMed |
| Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma. | Biomed Res Int | 2023 | 36814797 | PubTator, text mining | PubMed |
| Differential regulation of H3K9/H3K14 acetylation by small molecules drives neuron-fate-induction of glioma cell. | Cell Death Dis | 2023 | 36805688 | PubTator, text mining | PubMed |
| Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies. | Signal Transduct Target Ther | 2023 | 36797244 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7994/papers?page=14